Gamma Oryzanol Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

Gamma Oryzanol Market Summary Highlights

The Gamma Oryzanol Market is entering a phase of structurally diversified demand as nutraceutical manufacturers, functional food producers, and cosmetic formulators expand usage beyond traditional cholesterol-management applications. Increased rice bran oil processing capacity across Asia-Pacific and growing preference for plant-derived bioactive compounds are supporting raw material availability, while stricter scrutiny around synthetic additives in wellness products is accelerating adoption of naturally sourced antioxidants.

At the same time, the market faces pricing sensitivity linked to rice bran supply fluctuations, regional extraction inefficiencies, and inconsistent standardization of active concentrations across commercial-grade formulations. Demand momentum remains strongest in dietary supplements and sports nutrition, whereas pharmaceutical adoption continues to expand at a measured pace due to regulatory validation requirements and clinical substantiation costs.

The industry outlook through 2030 indicates moderate-to-strong expansion potential in premium-grade applications, especially in Asia-Pacific and North America, where functional ingredient penetration in consumer health products continues to rise.

Statistical Highlights – Gamma Oryzanol Market

• Global Gamma Oryzanol Market valuation is estimated at USD 1.05 billion in 2026, with projected CAGR of 7.1% through 2030.
• Dietary supplements account for nearly 38% of total Gamma Oryzanol demand in 2026, led by cardiovascular and metabolic health positioning.
• Functional foods and beverages contribute approximately 24% market share, supported by fortified edible oils, cereals, and wellness drinks.
• Asia-Pacific represents over 46% of global consumption volume, driven by rice bran oil production concentration in India, China, Japan, Thailand, and Vietnam.
• Pharmaceutical-grade Gamma Oryzanol products command pricing premiums of 28%–35% over food-grade variants due to purification requirements.
• Rice bran oil extraction output across Asia is projected to increase by 5.8% in 2026, strengthening feedstock supply availability.
• Natural antioxidant ingredients in nutraceutical formulations are expected to witness over 8% annual growth through 2030, indirectly supporting Gamma Oryzanol Market expansion.
• Sports nutrition applications using rice-derived phytosterol compounds are forecast to expand by approximately 9.3% annually between 2026 and 2030.
• Europe accounts for nearly 19% of cosmetic and personal care utilization of Gamma Oryzanol, particularly in anti-aging and UV-protection formulations.
• Standardized formulations containing more than 95% purity levels are projected to represent over 41% of premium commercial sales by 2028.
• Industrial extraction losses in low-efficiency processing facilities still reduce potential recoverable Gamma Oryzanol yields by an estimated 12%–18% globally.

Rising Functional Nutrition Consumption Reshaping the Gamma Oryzanol Market

The Gamma Oryzanol Market is increasingly being shaped by the global shift toward preventive nutrition and bioactive ingredient consumption. Consumers are prioritizing ingredients associated with cardiovascular support, antioxidant protection, inflammation management, and metabolic wellness. Gamma Oryzanol, extracted primarily from rice bran oil, aligns closely with these purchasing patterns because it combines phytosterols and ferulic acid esters in a naturally derived composition.

The expanding functional nutrition sector is a major demand accelerator. Global fortified food launches containing plant-based active compounds are projected to rise by more than 11% in 2026, particularly in categories such as heart-health beverages, fortified breakfast products, and wellness snacks. This has created stronger commercial interest in rice-derived nutraceutical ingredients that offer clean-label positioning without synthetic associations.

Japan continues to remain a mature but influential consumption center due to long-standing incorporation of rice bioactives into wellness products. Meanwhile, India and China are emerging as large-scale production and consumption hubs because of expanding rice bran processing infrastructure. India alone is expected to process more than 11 million metric tons of rice bran in 2026, creating favorable conditions for higher-value extraction industries linked to Gamma Oryzanol production.

Manufacturers are also increasingly positioning Gamma Oryzanol in formulations targeting aging populations. By 2026, nearly 17% of the global population is projected to be above 60 years of age, increasing demand for cholesterol-management supplements and antioxidant-rich nutraceuticals. This demographic trend is directly supporting the incorporation of rice phytosterol compounds into capsules, tablets, and fortified oils.

Expansion of Rice Bran Oil Processing Capacity

A significant structural driver for the Gamma Oryzanol Market is the modernization of rice bran oil extraction and refining infrastructure. Historically, underdeveloped extraction technologies limited commercial recovery rates and reduced profitability for processors. However, investments in solvent extraction optimization and cold-processing technologies are improving yields and purity levels.

Several Asian governments continue to encourage value-added agricultural processing to improve farmer income realization and reduce edible oil import dependence. This has stimulated capacity expansion in integrated rice milling and bran refining operations. In Southeast Asia, multiple mid-scale refining facilities commissioned between 2024 and 2026 are improving availability of stabilized rice bran feedstock for nutraceutical extraction.

Higher extraction efficiency is becoming commercially critical because Gamma Oryzanol concentrations in crude rice bran oil remain relatively low. Refiners are increasingly adopting molecular distillation and advanced filtration technologies to produce pharmaceutical-grade and cosmetic-grade variants with higher purity consistency.

This shift toward premium processing is altering competitive dynamics within the industry. Producers capable of supplying standardized active concentrations are securing stronger partnerships with international supplement manufacturers, especially in North America and Europe where formulation compliance standards remain stringent.

Cosmetic and Personal Care Integration Supporting New Revenue Streams

The Gamma Oryzanol Market is no longer dependent solely on nutraceutical demand. Cosmetic and dermatological applications are becoming increasingly important due to the compound’s antioxidant and UV-absorption characteristics.

Skincare manufacturers are incorporating Gamma Oryzanol into anti-aging creams, sun-protection products, serums, and skin barrier repair formulations. Demand growth is especially visible in South Korea, Japan, France, and Germany, where consumers increasingly favor botanical active ingredients over synthetic antioxidant systems.

The global premium skincare category is projected to expand by nearly 7% in 2026, while botanical antioxidant ingredient usage in cosmetic formulations is expected to rise faster than conventional synthetic alternatives. This transition is benefiting rice-derived active compounds because they offer multifunctional performance including oxidative stress reduction and lipid stabilization.

Cosmetic formulators are also using Gamma Oryzanol in hair-care products due to its potential protective effects against environmental damage and scalp dryness. Although this segment remains smaller than dietary supplements, it provides higher-margin opportunities for ingredient manufacturers.

Another important trend involves “beauty-from-within” nutraceuticals, where cosmetic and dietary positioning overlap. Supplement brands increasingly market antioxidant capsules targeting both skin wellness and cardiovascular support, expanding the addressable consumer base for Gamma Oryzanol suppliers.

Standardization Challenges and Pricing Pressure

Despite favorable demand fundamentals, the Gamma Oryzanol Market continues to face operational and commercial constraints. One of the most persistent issues is inconsistency in active concentration across commercial formulations.

The absence of globally harmonized purity benchmarks creates difficulties for downstream manufacturers attempting to ensure formulation stability and efficacy claims. Premium supplement brands increasingly require purity levels above 95%, but many small-scale processors continue supplying lower-standard material with inconsistent extraction profiles.

Feedstock volatility also remains a concern. Rice production is highly climate-sensitive, and fluctuations in paddy output directly affect rice bran availability. Irregular monsoon conditions in parts of Asia during recent harvest cycles have periodically increased raw material pricing pressure. Since rice bran deteriorates rapidly without stabilization, supply-chain inefficiencies can further reduce recoverable antioxidant content.

Energy-intensive refining processes are another challenge. Rising industrial utility costs in Asia and Europe are increasing production expenses for purified Gamma Oryzanol concentrates. As a result, smaller processors operating with outdated infrastructure are facing narrowing margins.

Price competition from alternative plant sterols and synthetic antioxidant systems also influences purchasing decisions in cost-sensitive markets. Food manufacturers operating in high-volume categories often prioritize lower-cost antioxidant blends, limiting penetration of premium rice-derived compounds in mass-market applications.

Sports Nutrition and Metabolic Wellness Trends Creating Future Opportunities

One of the most commercially promising developments in the Gamma Oryzanol Market is its increasing visibility in sports nutrition and metabolic wellness formulations. Manufacturers are positioning the ingredient in products associated with endurance support, recovery optimization, and hormone balance applications.

The global active nutrition consumer base continues to expand beyond professional athletes toward mainstream wellness users. By 2026, more than 420 million consumers worldwide are projected to purchase sports nutrition or performance-support supplements annually. This broader customer base is encouraging brands to incorporate plant-derived functional ingredients with cleaner-label perception.

Gamma Oryzanol’s association with lipid metabolism regulation and antioxidant support is strengthening its relevance in this category. Although regulatory frameworks prevent aggressive performance claims in several countries, demand for naturally sourced recovery-support ingredients continues to rise.

Looking ahead, the Gamma Oryzanol Market is expected to benefit from convergence between functional nutrition, preventive healthcare, and botanical ingredient innovation. Companies investing in extraction efficiency, formulation standardization, and application diversification are likely to strengthen long-term competitive positioning as global demand for plant-derived bioactive compounds continues to evolve.

Asia-Pacific Dominates the Gamma Oryzanol Market Supply Chain

Asia-Pacific continues to represent the operational center of the Gamma Oryzanol Market due to its dominance in rice cultivation, rice bran availability, and edible oil refining infrastructure. Countries including India, China, Japan, Thailand, and Vietnam collectively account for more than 70% of global rice production in 2026, creating a substantial feedstock base for Gamma Oryzanol extraction.

India has emerged as one of the most commercially influential markets because of expanding rice bran oil refining capacity and growing nutraceutical manufacturing activity. Data from the Indian Ministry of Agriculture and Farmers Welfare indicates rice output is projected to exceed 145 million metric tons in the 2025–2026 crop cycle, supporting larger bran recovery volumes for downstream processing industries. Increasing investments in solvent extraction facilities across states such as Uttar Pradesh, West Bengal, Haryana, and Andhra Pradesh are improving domestic value addition in rice-derived bioactive ingredients.

Japan remains a high-value consumption market rather than a high-volume producer. Demand is strongly linked to premium nutraceuticals, pharmaceutical formulations, and anti-aging cosmetic applications. Japanese food manufacturers continue to incorporate rice bioactives into cholesterol-management products, functional beverages, and wellness supplements targeted at aging consumers. The country’s mature functional food ecosystem gives pharmaceutical-grade Gamma Oryzanol products stronger commercial positioning compared to commodity nutraceutical ingredients.

China’s Gamma Oryzanol Market is being shaped by rising health supplement penetration and increasing consumer preference for plant-based active compounds. Functional food launches containing phytosterols and natural antioxidants continue to expand rapidly in urban retail channels. Chinese nutraceutical manufacturers are also increasing procurement of high-purity Gamma Oryzanol for combination formulations linked to cardiovascular health and metabolic wellness.

North America Expanding Through Nutraceutical Applications

North America represents one of the fastest-growing import-driven regions in the Gamma Oryzanol Market. The United States accounts for the majority of regional demand due to strong dietary supplement consumption and rising adoption of plant-derived antioxidant compounds in sports nutrition products.

The Council for Responsible Nutrition estimates that more than 79% of U.S. adults use dietary supplements in some form during 2026, creating favorable conditions for specialty nutraceutical ingredients. Gamma Oryzanol demand is increasing particularly in formulations associated with cholesterol management, hormonal balance, athletic recovery, and antioxidant support.

Sports nutrition applications are becoming commercially significant in the region. The active lifestyle consumer base continues expanding beyond professional athletes toward mainstream consumers seeking performance-support supplements with natural ingredient labels. This shift has encouraged supplement brands to diversify away from synthetic additive systems and incorporate rice-derived phytosterol compounds.

Canada is witnessing steady growth in premium wellness products and botanical nutraceutical categories, although overall market volume remains smaller than the United States. Regulatory emphasis on ingredient traceability and purity verification is supporting demand for standardized Gamma Oryzanol extracts sourced from certified Asian suppliers.

Europe Prioritizing Premium Cosmetic and Functional Food Demand

The European Gamma Oryzanol Market demonstrates a different consumption pattern compared to Asia-Pacific and North America. Cosmetic formulations and functional food applications contribute a larger share of regional demand.

France, Germany, Italy, and the United Kingdom remain major importers of high-purity antioxidant ingredients used in skincare and nutraceutical products. Botanical ingredient penetration in Europe’s premium cosmetics industry continues to accelerate as consumers increasingly prefer plant-derived active compounds over synthetic stabilizers and preservatives.

European skincare manufacturers are integrating Gamma Oryzanol into anti-aging creams, UV-protection formulations, and lipid barrier repair products. Functional positioning related to oxidative stress reduction and skin conditioning is gaining stronger commercial relevance in premium beauty categories.

Food manufacturers are also using rice-derived antioxidants in fortified edible oils, cereals, and wellness beverages. However, regulatory scrutiny under European food safety frameworks continues to influence commercialization speed. Ingredient suppliers capable of demonstrating purity consistency and traceable sourcing maintain stronger competitive positioning across the region.

Latin America and Middle East Emerging as Secondary Demand Centers

Although relatively smaller in scale, Latin America and the Middle East are gradually strengthening their position within the Gamma Oryzanol Market. Rising urbanization, increasing health awareness, and growing availability of imported nutraceutical products are supporting demand expansion.

Brazil leads Latin American consumption due to its expanding dietary supplement industry and strong retail presence of wellness-focused food products. Mexico is also witnessing higher demand for plant-derived antioxidant formulations, particularly in cardiovascular support supplements.

In the Middle East, demand is concentrated in premium nutrition and personal care sectors. Gulf countries are increasingly importing functional ingredients for high-end wellness brands catering to affluent consumers seeking preventive healthcare products. However, market penetration remains limited by higher product costs and lower consumer familiarity compared to established nutraceutical ingredients.

Gamma Oryzanol Market Segmentation Highlights

By Application

• Dietary supplements remain the largest segment, contributing approximately 38% of total Gamma Oryzanol Market revenue in 2026.
• Functional foods and beverages account for nearly 24% share, driven by fortified oils, nutritional bars, and wellness drinks.
• Cosmetic and personal care applications are projected to expand at over 8% CAGR through 2030 due to rising botanical skincare demand.
• Pharmaceutical formulations continue to grow steadily in Asia and Europe where cholesterol-management therapies using rice bioactives are commercially established.
• Sports nutrition applications are emerging rapidly, supported by increasing demand for plant-based recovery and metabolic wellness products.

By Purity Level

• Products containing more than 95% active purity are witnessing the strongest demand growth in North America and Europe.
• Medium-purity commercial grades continue dominating high-volume food applications because of lower production costs.
• Pharmaceutical-grade Gamma Oryzanol products maintain pricing premiums between 28% and 35% over conventional nutraceutical grades.

By Distribution Channel

• Direct business-to-business ingredient supply remains dominant, especially among nutraceutical and cosmetic manufacturers.
• E-commerce sales for retail supplement formulations are increasing significantly in the United States, China, Japan, and South Korea.
• Specialty wellness retail channels are expanding faster than conventional pharmacy distribution in urban Asian markets.

Gamma Oryzanol Production Expanding with Rice Bran Processing Investments

Gamma Oryzanol production is closely linked to rice bran oil refining activity because the compound is primarily extracted during oil processing stages. As rice-producing countries modernize edible oil infrastructure, commercial extraction capacity for nutraceutical-grade compounds is increasing steadily.

Global Gamma Oryzanol production in 2026 is estimated to exceed 8,500 metric tons, supported by expansion in integrated rice milling and solvent extraction facilities across Asia-Pacific. India and China together account for more than half of worldwide Gamma Oryzanol production capacity due to abundant rice bran availability and lower processing costs.

Technological upgrades are improving Gamma Oryzanol production efficiency. Advanced molecular distillation systems and precision filtration technologies are enabling higher recovery rates while reducing active compound degradation during refining. Several mid-sized Asian processors commissioned between 2024 and 2026 have increased pharmaceutical-grade Gamma Oryzanol production targeted at export-oriented nutraceutical and cosmetic industries.

Production economics, however, remain sensitive to rice bran stabilization quality and energy-intensive refining processes. Inadequate storage conditions can rapidly reduce antioxidant content in raw bran feedstock, limiting extractable yields and increasing processing losses.

Gamma Oryzanol Price Trend Reflecting Feedstock and Purity Dynamics

The Gamma Oryzanol Price environment in 2026 remains influenced by rice bran availability, extraction efficiency, purity levels, and regional energy costs. Pharmaceutical-grade products continue trading at significantly higher price points due to stringent purification and standardization requirements.

Average Gamma Oryzanol Price levels for high-purity nutraceutical grades increased by approximately 6%–8% during the first half of 2026 compared to the previous year. Rising utility costs across Asian manufacturing hubs and intermittent feedstock tightness contributed to this upward movement.

The Gamma Oryzanol Price Trend also reflects growing demand from cosmetic and sports nutrition industries, both of which require premium standardized formulations. Suppliers capable of ensuring stable active concentration levels and traceable sourcing are securing stronger long-term contracts with multinational supplement and skincare manufacturers.

At the same time, price volatility remains a concern for smaller buyers. Seasonal fluctuations in rice harvest output continue affecting bran availability across India and Southeast Asia. Climate-related production disruptions and inconsistent storage infrastructure periodically tighten supply conditions, particularly for pharmaceutical-grade material.

The long-term Gamma Oryzanol Price Trend is expected to remain moderately upward through 2030 as global demand for natural antioxidant ingredients expands faster than high-purity extraction capacity additions. However, large-scale investments in integrated rice bran refining facilities could gradually stabilize supply dynamics and reduce extreme pricing fluctuations in the later part of the forecast period.

Competitive Landscape of the Gamma Oryzanol Market

The Gamma Oryzanol Market remains moderately consolidated, with Japanese and Asian manufacturers controlling a significant share of global high-purity production capacity. Companies operating integrated rice bran oil refining and extraction facilities maintain stronger competitive positioning because direct access to stabilized rice bran feedstock improves cost efficiency, supply consistency, and purity control.

The market is increasingly shifting from commodity-oriented production toward premium nutraceutical and cosmetic applications. Manufacturers are competing on extraction technology, active concentration standardization, pharmaceutical-grade purity, and application-specific formulations. This transition is reshaping the competitive structure of the Gamma Oryzanol Market, particularly in North America, Europe, and developed Asian economies where regulatory and quality requirements are stricter.

The top five manufacturers collectively account for more than 60% of the global Gamma Oryzanol Market share in 2026. Japanese suppliers continue dominating premium-grade formulations, while Indian and Chinese producers are expanding aggressively in cost-competitive bulk supply categories.

Oryza Oil & Fat Chemical Co., Ltd.

Oryza Oil & Fat Chemical remains one of the most influential manufacturers in the Gamma Oryzanol Market. The company has built strong market recognition through its ORYZA GAMMAX product line, which is widely utilized in nutraceutical supplements, functional foods, and cosmetic formulations.

Its strength lies in advanced purification technologies and high-purity antioxidant extraction systems. The company has also focused heavily on formulation stability and regulatory acceptance, enabling stronger penetration into premium supplement and skincare markets across Japan, Europe, and North America.

Oryza Oil & Fat Chemical is estimated to hold approximately 18%–22% of the global premium Gamma Oryzanol Market share in 2026.

TSUNO Group

TSUNO Group continues to maintain a leading position in pharmaceutical-grade and food-grade Gamma Oryzanol production. The company benefits from vertically integrated rice bran processing infrastructure and advanced molecular distillation technologies that improve extraction efficiency and purity consistency.

TSUNO’s Gamma Oryzanol ingredients are widely used in cholesterol-management supplements, functional edible oils, antioxidant capsules, and wellness beverages. The company also maintains increasing exposure to cosmetic applications linked to anti-aging and oxidative stress protection.

Its estimated global market share ranges between 15% and 18%, particularly strong in high-value export markets.

Ricela Group

Ricela Group has emerged as one of India’s most significant rice bran oil and nutraceutical ingredient producers. The company benefits from large-scale rice milling integration and access to abundant rice bran feedstock.

Ricela’s Gamma Oryzanol-rich formulations are increasingly supplied to functional food companies, edible oil brands, and dietary supplement manufacturers across Asia and the Middle East. The company’s expansion reflects the broader rise of India as an important processing and export hub within the Gamma Oryzanol Market.

Its estimated global market share is close to 8%–10% in 2026.

Sunrise Nutrachem Group

Sunrise Nutrachem Group has strengthened its presence through bulk nutraceutical ingredient exports and botanical extract manufacturing. The company primarily serves dietary supplement manufacturers seeking cost-competitive antioxidant and phytosterol ingredients.

Its growth strategy has focused on expanding export volumes to North America and Europe, where demand for plant-derived wellness compounds continues to rise steadily.

Kangcare Bioindustry

Kangcare Bioindustry remains active in botanical ingredient formulations and functional nutraceutical compounds. The company supplies Gamma Oryzanol ingredients for capsules, tablets, and wellness blends targeting cardiovascular and metabolic health categories.

Chinese manufacturers such as Kangcare are benefiting from increasing domestic supplement consumption as well as rising export demand for standardized plant-derived antioxidant ingredients.

A.P. Refinery Pvt. Ltd.

A.P. Refinery has strengthened its position through expansion in rice bran oil refining and Gamma Oryzanol extraction capabilities. The company primarily serves food-grade and nutraceutical-grade markets, although it is gradually increasing participation in higher-purity applications.

Investments in refining infrastructure and extraction optimization are helping Indian suppliers improve competitiveness against established Japanese producers.

Modi Naturals Ltd.

Modi Naturals continues to expand its focus on value-added rice bran oil products enriched with Gamma Oryzanol positioning. The company has increasingly emphasized heart-health and antioxidant marketing strategies within India’s growing urban wellness market.

Its consumer-oriented branding approach reflects the rising importance of functional edible oils in the broader Gamma Oryzanol Market ecosystem.

Adani Wilmar Ltd.

Adani Wilmar is leveraging large-scale edible oil distribution networks to promote rice bran oil products with enhanced Gamma Oryzanol content. Functional nutrition positioning linked to cholesterol management and antioxidant support has improved visibility of Gamma Oryzanol-rich edible oils among health-conscious consumers in India.

Gamma Oryzanol Market Share by Manufacturers

The Gamma Oryzanol Market share structure in 2026 reflects a combination of technological expertise, raw material integration, and export capability. Japanese manufacturers dominate premium pharmaceutical and cosmetic-grade categories due to superior purification technologies and stronger international compliance standards.

Indian manufacturers maintain advantages in large-scale rice bran availability and lower production costs, enabling competitive supply to high-volume nutraceutical and edible oil markets. Chinese producers continue expanding rapidly in botanical ingredient exports and standardized supplement formulations.

Approximately 35%–40% of the market remains fragmented among regional processors and mid-sized extraction companies supplying food-grade and industrial applications. However, consolidation is gradually increasing as international buyers prioritize traceability, purity consistency, and long-term supply reliability.

Competition is increasingly shifting toward formulation innovation rather than basic extraction capacity alone. Manufacturers are investing in higher-purity formulations exceeding 95% active concentration because premium nutraceutical and cosmetic buyers require standardized ingredients for regulatory and efficacy purposes.

Product Innovation Strategies

Manufacturers across the Gamma Oryzanol Market are increasingly moving toward branded ingredient platforms instead of bulk commodity supply. This transition is especially visible in nutraceutical and cosmetic sectors where formulation differentiation supports stronger pricing power.

Several companies are developing combination formulations incorporating phytosterols, tocotrienols, ferulic acid compounds, and antioxidant blends alongside Gamma Oryzanol. Multi-functional wellness positioning is becoming commercially important as supplement brands seek broader cardiovascular and metabolic health applications.

Cosmetic ingredient innovation is also accelerating. Manufacturers are collaborating with skincare companies to develop formulations targeting UV protection, oxidative stress reduction, anti-aging support, and skin barrier enhancement. This category continues generating higher margins compared to conventional food-grade applications.

Recent News and Industry Developments

• July 2025 – KRBL Limited launched the India Gate Uplife edible oil range with higher Gamma Oryzanol concentrations focused on wellness-oriented consumers and heart-health positioning.
• 2025 – Oryza Oil & Fat Chemical expanded commercial promotion of ORYZA GAMMAX formulations for nutraceutical and cosmetic applications across Europe and North America.
• Late 2024 to 2026 – Multiple rice bran processors across India, Japan, and Southeast Asia upgraded molecular distillation and extraction infrastructure to improve pharmaceutical-grade Gamma Oryzanol recovery rates.
• 2025 – Chinese nutraceutical manufacturers increased exports of standardized Gamma Oryzanol formulations to the United States and Europe due to rising demand for plant-derived antioxidant ingredients.
• 2026 – Functional edible oil brands across Asia intensified marketing campaigns centered on natural antioxidant enrichment and cholesterol-management positioning associated with Gamma Oryzanol-rich rice bran oil.
• 2025–2026 – Cosmetic manufacturers in South Korea, France, and Japan expanded use of Gamma Oryzanol in anti-aging creams, UV-defense formulations, and botanical skincare systems.